SI2513119T1 - 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati - Google Patents

3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati

Info

Publication number: SI2513119T1
Authority: SI; Slovenia
Prior art keywords: cćisoquinoline; thiopyrano; tetrahydro; derivatives; cćisoquinoline derivatives
Prior art date: 2009-12-18

Application number

SI201030746T

Other languages

English (en)

Inventor

Dieter Flockerzi

Thomas Stengel

Alexander Mann

Harald Ohmer

Ulrich Kautz

Steffen Weinbrenner

Stefan Fischer

Christof Zitt

Armin Hatzelmann

Torsten Dunkern

Christian Hesslinger

Thomas Maier

Hermann Tenor

Clemens Braun

Raimund Kulzer

Degenhard Marx

Original Assignee

Takeda Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-18

Filing date

2010-12-15

Publication date

2014-10-30

2010-12-15 Application filed by Takeda Gmbh filed Critical Takeda Gmbh

2014-10-30 Publication of SI2513119T1 publication Critical patent/SI2513119T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Hematology (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Gynecology & Obstetrics (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)

SI201030746T 2009-12-18 2010-12-15 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati SI2513119T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP09179982		2009-12-18
US31555210P	2010-03-19	2010-03-19
EP10790569.7A EP2513119B1 (en)	2009-12-18	2010-12-15	3,4,4a,10b-tetrahydro-1h-thiopyrano-[4,3-c]isoquinoline derivatives
PCT/EP2010/069704 WO2011073231A1 (en)	2009-12-18	2010-12-15	3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c] ISOQUINOLINE DERIVATIVES

Publications (1)

Publication Number	Publication Date
SI2513119T1 true SI2513119T1 (sl)	2014-10-30

Family

ID=41718903

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201030746T SI2513119T1 (sl)	2009-12-18	2010-12-15	3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati

Country Status (29)

Country	Link
US (1)	US9018175B2 (sl)
EP (2)	EP2513119B1 (sl)
JP (1)	JP5645961B2 (sl)
KR (1)	KR20120123313A (sl)
CN (1)	CN102652136B (sl)
AR (1)	AR079451A1 (sl)
AU (1)	AU2010332955B8 (sl)
BR (1)	BR112012014058A8 (sl)
CA (1)	CA2784013A1 (sl)
CO (1)	CO6551705A2 (sl)
DK (1)	DK2513119T3 (sl)
EA (1)	EA023212B1 (sl)
ES (2)	ES2505290T3 (sl)
GE (1)	GEP20146105B (sl)
HR (1)	HRP20140893T1 (sl)
ME (1)	ME01914B (sl)
MX (1)	MX2012006696A (sl)
NZ (1)	NZ601115A (sl)
PH (1)	PH12012501125A1 (sl)
PL (1)	PL2513119T3 (sl)
PT (1)	PT2513119E (sl)
RS (1)	RS53544B1 (sl)
SG (2)	SG180824A1 (sl)
SI (1)	SI2513119T1 (sl)
SM (1)	SMT201400185B (sl)
TW (1)	TWI468411B (sl)
UA (1)	UA107689C2 (sl)
WO (1)	WO2011073231A1 (sl)
ZA (1)	ZA201204135B (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2577777B1 (en)	2010-06-07	2016-12-28	Sapurast Research LLC	Rechargeable, high-density electrochemical device
RU2013142268A (ru) *	2011-02-17	2015-03-27	Сипла Лимитед	Фармацевтическая композиция
EP2721036B1 (en) *	2011-06-15	2015-07-22	Takeda GmbH	Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
WO2014016548A2 (en) *	2012-07-27	2014-01-30	Cipla Limited	Pharmaceutical composition
WO2014090990A1 (en) *	2012-12-13	2014-06-19	Ludwig Aigner	Leukotriene pathway antagonists for the treatment of dementia, cognitive deficits in parkinson's disease and/or learning and memory deficiencies in parkinson's disease
WO2014117947A1 (en)	2013-02-04	2014-08-07	Grünenthal GmbH	4-amino substituted condensed pyrimidine compounds as pde4 inhibitors
KR20150119370A (ko)	2013-02-19	2015-10-23	화이자 인코포레이티드	Cns 장애 및 다른 장애의 치료를 위한 pde4 동종효소의 억제제로서의 아자벤즈이미다졸 화합물
EP3172210B1 (en)	2014-07-24	2020-01-15	Pfizer Inc	Pyrazolopyrimidine compounds
WO2016020786A1 (en)	2014-08-06	2016-02-11	Pfizer Inc.	Imidazopyridazine compounds
WO2017089347A1 (en)	2015-11-25	2017-06-01	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
WO2022006470A1 (en)	2020-07-01	2022-01-06	Vanderbilt University	Methods of treatment for a kidney disease

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3899494A (en)	1970-05-13	1975-08-12	Sandoz Ltd	Substituted 6-phenyl benzo-naphthyridines
DE2047465A1 (de)	1970-09-26	1972-03-30	Farbwerke Hoechst AG, vorm Meister Lucius & Bruning, 6000 Frankfurt	Neue Oxdiazole und Verfahren zu lh rer Herstellung
CN1003445B (zh)	1984-10-03	1989-03-01	武田药品工业株式会社	噻唑烷二酮衍生物，其制备方法和用途
JPH01213284A (ja)	1988-02-22	1989-08-28	Sankyo Co Ltd	チエノピリミジン−２，４−ジオン誘導体
GB8828477D0 (en)	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
EP0407028B2 (en)	1989-05-31	1999-07-07	FISONS plc	Medicament inhalation device and formulation
GB8921222D0 (en)	1989-09-20	1989-11-08	Riker Laboratories Inc	Medicinal aerosol formulations
IL97065A (en)	1990-02-02	1994-01-25	Fisons Plc	Repellent preparations for aerosol
DE4003272A1 (de)	1990-02-03	1991-08-08	Boehringer Ingelheim Kg	Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
EP0965335B1 (en)	1990-03-23	2003-09-17	Minnesota Mining And Manufacturing Company	Metered-dose aerosol formulations
JP2769925B2 (ja)	1990-10-18	1998-06-25	ミネソタマイニングアンドマニュファクチャリングカンパニー	ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
AU650953B2 (en)	1991-03-21	1994-07-07	Novartis Ag	Inhaler
IL104068A (en)	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9213874D0 (en)	1992-06-30	1992-08-12	Fisons Plc	Process to novel medicament form
GB9306703D0 (en)	1993-03-31	1993-05-26	Fisons Plc	Inhalation device
IL111194A (en)	1993-10-08	1998-02-08	Fisons Plc	Process for the production of medicament formulations
ATE234300T1 (de)	1996-11-11	2003-03-15	Altana Pharma Ag	Benzonaphthyridine als bronchialtherapeutika
US6200975B1 (en)	1997-05-08	2001-03-13	Merck Sharp & Dohme Limited	Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands
DK0988302T3 (da)	1997-06-03	2003-06-02	Altana Pharma Ag	Benzonaphthyridiner
DK1102579T3 (da)	1998-08-04	2003-07-14	Jago Res Ag	Medicinske aerosolformuleringer
US6397838B1 (en)	1998-12-23	2002-06-04	Battelle Pulmonary Therapeutics, Inc.	Pulmonary aerosol delivery device and method
US6454193B1 (en)	1999-04-23	2002-09-24	Battellepharma, Inc.	High mass transfer electrosprayer
WO2000064590A1 (en)	1999-04-23	2000-11-02	Battelle Memorial Institute	Directionally controlled ehd aerosol sprayer
DE60024861T2 (de)	1999-10-28	2006-07-06	Trine Pharmaceuticals, Inc., Waltham	Pumpeninhibitoren zur freisetzung von medikamenten
CA2411013A1 (en)	2000-06-07	2001-12-13	Jose Manuel Prieto Soto	6-phenylpyrrolopyrimidinedione derivatives
WO2002005616A1 (en)	2000-07-14	2002-01-24	Altana Pharma Ag	Novel 6-phenylphenanthridines
PL199420B1 (pl)	2000-10-09	2008-09-30	3M Innovative Properties Co	Medyczne preparaty aerozolowe
JP2005504043A (ja)	2001-08-10	2005-02-10	パラチンテクノロジーズインク．	生物学的に活性な金属ペプチド類のペプチド模倣体類
US20030216407A1 (en)	2002-01-31	2003-11-20	Pfizer Inc.	Use of PDE5 inhibitors in the treatment of scarring
GB0202254D0 (en)	2002-01-31	2002-03-20	Pfizer Ltd	Prevention of scarring
AU2003253165A1 (en)	2002-08-13	2004-02-25	Warner-Lambert Company Llc	Pyrimidine fused bicyclic metalloproteinase inhibitors
KR20070007945A (ko)	2004-04-23	2007-01-16	셀진 코포레이션	폐 고혈압증의 치료 및 관리를 위한 ｐｄｅ4 조절인자의사용 방법 및 그를 포함하는 조성물
US7838521B2 (en)	2004-09-08	2010-11-23	Nycomed Gmbh	3-oxa-10-aza-phenanthrenes
EP1791847A2 (en)	2004-09-08	2007-06-06	Altana Pharma AG	Novel 3-thia-10-aza-phenanthrene derivatives
JP4943858B2 (ja)	2004-11-17	2012-05-30	キッセイ薬品工業株式会社	芳香族アミド誘導体、それを含有する医薬組成物およびそれらの医薬用途
WO2006095009A1 (en)	2005-03-09	2006-09-14	Nycomed Gmbh	Amido-substituted 6-phenylphenanthridines
MX2009011089A (es)	2007-04-23	2009-10-30	Sanofi Aventis	Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12.
EP2721036B1 (en) *	2011-06-15	2015-07-22	Takeda GmbH	Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds

2010
- 2010-12-14 AR ARP100104617A patent/AR079451A1/es unknown
- 2010-12-15 EP EP10790569.7A patent/EP2513119B1/en active Active
- 2010-12-15 EA EA201200891A patent/EA023212B1/ru not_active IP Right Cessation
- 2010-12-15 CA CA2784013A patent/CA2784013A1/en not_active Abandoned
- 2010-12-15 US US13/515,214 patent/US9018175B2/en not_active Expired - Fee Related
- 2010-12-15 PL PL10790569T patent/PL2513119T3/pl unknown
- 2010-12-15 ES ES10790569.7T patent/ES2505290T3/es active Active
- 2010-12-15 RS RSP20140499 patent/RS53544B1/sr unknown
- 2010-12-15 GE GEAP201012783A patent/GEP20146105B/en unknown
- 2010-12-15 WO PCT/EP2010/069704 patent/WO2011073231A1/en not_active Ceased
- 2010-12-15 CN CN201080057293.7A patent/CN102652136B/zh not_active Expired - Fee Related
- 2010-12-15 ES ES14164018.5T patent/ES2621291T3/es active Active
- 2010-12-15 KR KR1020127017957A patent/KR20120123313A/ko not_active Withdrawn
- 2010-12-15 ME MEP-2014-114A patent/ME01914B/me unknown
- 2010-12-15 PT PT107905697T patent/PT2513119E/pt unknown
- 2010-12-15 SG SG2012034732A patent/SG180824A1/en unknown
- 2010-12-15 EP EP14164018.5A patent/EP2813509B1/en active Active
- 2010-12-15 DK DK10790569.7T patent/DK2513119T3/da active
- 2010-12-15 SI SI201030746T patent/SI2513119T1/sl unknown
- 2010-12-15 BR BR112012014058A patent/BR112012014058A8/pt not_active IP Right Cessation
- 2010-12-15 AU AU2010332955A patent/AU2010332955B8/en not_active Ceased
- 2010-12-15 SG SG2014000335A patent/SG196785A1/en unknown
- 2010-12-15 UA UAA201208482A patent/UA107689C2/ru unknown
- 2010-12-15 NZ NZ601115A patent/NZ601115A/en not_active IP Right Cessation
- 2010-12-15 MX MX2012006696A patent/MX2012006696A/es active IP Right Grant
- 2010-12-15 JP JP2012543701A patent/JP5645961B2/ja not_active Expired - Fee Related
- 2010-12-15 HR HRP20140893AT patent/HRP20140893T1/hr unknown
- 2010-12-15 PH PH1/2012/501125A patent/PH12012501125A1/en unknown
- 2010-12-17 TW TW99144591A patent/TWI468411B/zh not_active IP Right Cessation
2012
- 2012-05-24 CO CO12085785A patent/CO6551705A2/es active IP Right Grant
- 2012-06-06 ZA ZA2012/04135A patent/ZA201204135B/en unknown
2014
- 2014-12-11 SM SM201400185T patent/SMT201400185B/xx unknown

Also Published As

Publication number	Publication date
BR112012014058A2 (pt)	2017-10-24
AU2010332955A1 (en)	2012-08-02
JP5645961B2 (ja)	2014-12-24
ES2621291T3 (es)	2017-07-03
AU2010332955B8 (en)	2015-05-21
BR112012014058A8 (pt)	2018-02-06
PH12012501125A1 (en)	2012-10-29
KR20120123313A (ko)	2012-11-08
MX2012006696A (es)	2012-07-17
JP2013514308A (ja)	2013-04-25
PL2513119T3 (pl)	2014-11-28
ZA201204135B (en)	2013-03-27
EP2813509B1 (en)	2017-02-01
SMT201400185B (it)	2015-01-15
SG180824A1 (en)	2012-07-30
NZ601115A (en)	2014-05-30
AR079451A1 (es)	2012-01-25
RS53544B1 (sr)	2015-02-27
ES2505290T3 (es)	2014-10-09
EP2513119A1 (en)	2012-10-24
SG196785A1 (en)	2014-02-13
AU2010332955B2 (en)	2015-01-22
US9018175B2 (en)	2015-04-28
CN102652136A (zh)	2012-08-29
TWI468411B (zh)	2015-01-11
WO2011073231A1 (en)	2011-06-23
CN102652136B (zh)	2014-11-26
CO6551705A2 (es)	2012-10-31
AU2010332955A8 (en)	2015-05-28
TW201130851A (en)	2011-09-16
EA201200891A1 (ru)	2013-01-30
PT2513119E (pt)	2014-09-05
GEP20146105B (en)	2014-05-27
UA107689C2 (xx)	2015-02-10
ME01914B (me)	2015-05-20
EA023212B1 (ru)	2016-05-31
EP2813509A1 (en)	2014-12-17
DK2513119T3 (da)	2014-10-06
US20120289474A1 (en)	2012-11-15
CA2784013A1 (en)	2011-06-23
HRP20140893T1 (hr)	2014-11-07
EP2513119B1 (en)	2014-06-25
HK1174326A1 (en)	2013-06-07

Publication	Publication Date	Title
IL206765A0 (en)	2010-12-30	4,5-dihydro-oxazol-2-yl-amine derivatives
AP2012006216A0 (en)	2012-04-30	Benzimidazole-imidazole derivatives.
ZA201205788B (en)	2015-05-27	1,2,4-triazine-4-amine derivatives
IL241360A0 (en)	2015-11-30	Disubstituted 2-acetamido-5-aryl-4,2,1-triazole
IL210548A0 (en)	2011-03-31	Spiroaminodihydrothiazine derivatives
ZA201100799B (en)	2011-10-26	Imidazopyridin-2-one derivatives
SG10201506608RA (en)	2015-09-29	3-deazaneplanocin derivatives
ZA201100876B (en)	2011-10-26	Pyrrolopyridinylpyrimidin-2-ylamine derivatives
ZA201102449B (en)	2011-12-28	Morpholinopurine derivatives
ZA201102315B (en)	2012-06-27	7-piperidinoalkyl-3,4-dihyfroquinolone derivative
IL210869A0 (en)	2011-04-28	Imidazothiadiazoles derivatives
IL208336A0 (en)	2010-12-30	Pyrisazinone derivatives
SI2513119T1 (sl)	2014-10-30	3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati
IL211290A0 (en)	2011-04-28	New 2-amidothiadiazole derivatives
IL210613A0 (en)	2011-03-31	Novel acylaminobenzamide derivatives
ZA201005382B (en)	2011-10-26	Substituted heteroarylamide diazepinopyrimidone derivatives
IL210164A0 (en)	2011-03-31	Thiazolylpiperidine derivatives
ZA201005381B (en)	2011-10-26	Substituted heteroarylamide oxazepinopyrimidone derivatives
ZA201105050B (en)	2012-03-28	Quinazolinamide derivatives
EP2448934A4 (en)	2012-12-05	DERIVATIVES OF 2-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN
ZA201008052B (en)	2012-04-25	2-phenyl-4-cyclopropyl-pyrimidine derivatives
MY165626A (en)	2018-04-18	1,2,4,-triazolone derivative
ZA201005346B (en)	2011-11-30	3,8-diaminotetrahydroquinoline derivative
GB2476643B (en)	2012-11-14	1,4-Dihydro-1,4-dioxonaphtalene derivatives as anticoagulants
IL213762A0 (en)	2011-07-31	1,1,1-trifluoro-2-hydroxypropyl compounds